Donation

Would you like to make a donation to The Angel Fund?

The Angel Fund for ALS Research is an independent nonprofit charity benefiting ALS research at the Cecil B. Day Laboratory for Neuromuscular Research at UMASS Medical School in Worcester. 
 
Dr. Robert H. Brown, Jr. and his team at UMass Medical School are working on amazing cutting-edge research turning off mutant genes that cause ALS and bringing the research to HUMAN TRIALS. There has never been such promising research than that which is happening right now in the lab. So much is being done with innovative approaches toward a treatment.

ALS is a progressive and ultimately fatal neurological disease that attacks the motor neurons in the brain, brain stem and spinal cord. The resulting motor neuron loss causes increasingly debilitating paralysis as the muscles of the body waste away. Death comes when victims lose critical functions such as the ability to swallow and ultimately, to breathe.

ALS is particularly insidious because the intellect remains intact while ALS victims gradually lose the ability to control their muscles, to communicate, and eventually to breathe. There is no known cure for ALS, and death usually occurs in 2 to 5 years.

Thank you for any help you can provide in our fight against this devastating disease. For more information, please visit www.theangelfund.org.

 

NOTE TO RUNNERS: A fundraising page will be automatically created for you when you register. On your payment confirmation page, you will see yourself listed as a new fundraiser. Do not be confused when you see this-- it's supposed to be there!
You will receive an email soon with more instructions re: how to set up your fundraising page. You can choose to use it or not use it -- but we hope that you do. Thank you in advance for anything you can do to help this worthy cause!

 


Enter a custom donation amount or select a donation level above.

$


We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy. If you continue to use this site, you consent to use all cookies.